Kitasamycin monoclonal antibody hybridoma cell strain SML and application thereof
A hybridoma cell line, monoclonal antibody technology, applied in the preparation of hybrid peptides, sugar derivatives, animal/human proteins, etc. The effect of detection sensitivity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0035] Example 1 Preparation of kitasarmycin monoclonal antibody
[0036] (1) Preparation of hapten: The hapten KIT-CMO was prepared by the CMO method.
[0037]The specific method is as follows: Weigh 200 mg of KIT into a round bottom flask, add 30 mg, 0.24 mmol of CMO, add 5 mL of methanol and 5 mL of 0.02 M NaHCO 3 The buffer solution was placed in a constant temperature magnetic stirring water bath at 60°C for 12 hours of reaction. After the reaction, the reaction liquid was blown dry with a nitrogen blower. Particulate matter (primarily removing NaHCO which provides an alkaline environment 3 particles), and the methanol phase was blown dry again to obtain white kitasamycin oximated derivatives (KIT-CMO). Store in a 4°C refrigerator for later use. Identification by liquid chromatography-mass spectrometry, as attached figure 1 shown.
[0038] (2) Preparation of complete antigen: The immunogen KIT-EDC-BSA was synthesized by the activated ester (EDC) method, and the coati...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com